Search Login Register

Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor) Summary

Description: A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414)

Also Known As: Monoamine Oxidase Inhibitor; Reversible Inhibitor of Monoamine Oxidase; MAO Inhibitors; RIMA (Reversible Inhibitor of Monoamine Oxidase A); Inhibitor, Monoamine Oxidase Show All >>

Networked: 686 relevant articles (63 outcomes, 69 trials/studies) for this Bio-Agent

Key Diseases for which Monoamine Oxidase Inhibitors is Relevant

  1. Panic Disorder (Panic Attack) : 19 outcomes 6 studies in 46 results
  2. Phobic Disorders (Phobia) : 11 outcomes 8 studies in 31 results
  3. Agoraphobia : 6 outcomes 2 studies in 9 results
  4. Bipolar Disorder (Mania) : 5 outcomes 2 studies in 22 results
  5. Anxiety Disorders (Anxiety Disorder) : 5 outcomes 2 studies in 19 results
Show All >>

Drugs Related to Monoamine Oxidase Inhibitors

  1. Tricyclic Antidepressive Agents (Tricyclic Antidepressants)
  2. Benzodiazepines
  3. Serotonin Uptake Inhibitors (Serotonin Reuptake Inhibitors)
  4. Antidepressive Agents (Antidepressants)
  5. Monoamine Oxidase (MAO)
  6. Phenelzine (Nardil)
  7. Alprazolam (Xanax)
  8. Imipramine (Janimine)
  9. Serotonin (5 Hydroxytryptamine)
  10. Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)
Show All >>

Therapies Related to Monoamine Oxidase Inhibitors

  1. Blood Pressure Monitors
  2. Drug Therapy (Chemotherapy)
  3. Subcutaneous Injections
  4. Intraperitoneal Injections
  5. Injections
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.